- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 471/02 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups in which the condensed system contains two hetero rings
Patent holdings for IPC class C07D 471/02
Total number of patents in this class: 576
10-year publication summary
|
31
|
24
|
22
|
10
|
18
|
31
|
20
|
38
|
29
|
12
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
19 |
| Incyte Corporation | 918 |
17 |
| Merck Sharp & Dohme LLC | 3689 |
12 |
| SmithKline Beecham Corporation | 304 |
10 |
| Janssen Pharmaceutica N.V. | 3839 |
9 |
| Merck Patent GmbH | 5909 |
9 |
| Merck & Co., Inc. | 607 |
7 |
| Merck Sharp & Dohme Corp. | 2247 |
7 |
| Boehringer Ingelheim International GmbH | 4629 |
7 |
| Vertex Pharmaceuticals Incorporated | 1581 |
7 |
| Cytokinetics, Inc. | 259 |
7 |
| Incyte Holdings Corporation | 609 |
7 |
| Janssen Pharmaceuticals, Inc. | 399 |
6 |
| Novartis AG | 11238 |
5 |
| Hoffmann-La Roche Inc. | 3060 |
5 |
| 3m Innovative Properties Company | 18406 |
5 |
| Amgen Inc. | 3779 |
5 |
| Abbvie Inc. | 1808 |
5 |
| BeiGene, Ltd. | 319 |
5 |
| Medshine Discovery Inc. | 581 |
5 |
| Other owners | 417 |